SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000912057-00-008910
Filing Date
2000-02-29
Accepted
2000-02-29 00:00:00
Documents
6
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D 25285
2 EXHIBIT 99.A EX-99.A 2053
3 EXHIBIT 99.B EX-99.B 54605
4 EXHIBIT 99.C EX-99.C 7412
5 EXHIBIT 99.D EX-99.D 32047
6 EXHIBIT 99.E EX-99.E 22925
  Complete submission text file 0000912057-00-008910.txt   146851
Mailing Address
Business Address 1375 AKRON STREET P O BOX 1001 COPIAGUE NY 11726 5167892600
AMERICAN BIOGENETIC SCIENCES INC (Subject) CIK: 0000856984 (see all company filings)

IRS No.: 112655906 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45379 | Film No.: 556675
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice